ArticleProceedings of the National Academy of Sciences of the United States of America2024

Engineered CD4 T cells for in vivo delivery of therapeutic proteins.

Harikrishnan Radhakrishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.